After using the Viaskin patch for 3 years, 52% of peanut-allergic kids aged 4-11 could tolerate at least 1,000 milligrams of peanut protein.| Allergic Living
The future of the peanut patch immunotherapy treatment is uncertain after a Phase 3 trial failed to meet its main statistical goal.| Allergic Living
The website from which you got to this page is protected by Cloudflare. Email addresses on that page have been hidden in order to keep them from being accessed by malicious bots. You must enable Javascript in your browser in order to decode the e-mail address.| www.allergicliving.com